Skip Navigation

VAERS Bibliography - April 2005

  1. Elimination of Rubella and Congenital Rubella Syndrome--United States, 1969-2004.   MMWR Morb Mortal Wkly Rep; 54 (11): 279-282; March 25, 2005.

  2. Varicella Surveillance in Public Elementary Schools--Multnomah County, Oregon, 2002-2004.   MMWR Morb Mortal Wkly Rep; 54 (11): 274-276; March 25, 2005.

  3. Varicella-Related Deaths--United States, January 2003-June 2004.   MMWR Morb Mortal Wkly Rep; 54 (11): 272-274; March 25, 2005.

  4. Winter's a Wonderland, but Dangerous, Too. Mortality Rates Go Up During the Next Few Months. To Stay Healthy, Stay Warm and Vaccinated--and Install Carbon Monoxide Detectors.   Harv Health Lett; 30 (3): 4-5; January, 2005.

  5. [Effects of Vaccination Against Influenza on Progression of Chronic Obstructive Pulmonary Diseases].Ter Arkh; 77 (1): 59-62; 2005.

  6. Hospital Initiative Sees Higher Vaccination Rates.   Hosp Case Manag; 13 (3): 44-45; March, 2005.

  7. Progress in Reducing Measles Mortality--Worldwide, 1999-2003.  MMWR Morb Mortal Wkly Rep; 54 (8): 200-203; March 4, 2005.

  8. Vaccination Coverage Among Callers to a State Influenza Hotline--Connecticut, 2004-05 Influenza Season. MMWR Morb Mortal Wkly Rep; 54 (8): 199-200; March 4, 2005.

  9. Interventions to Increase Influenza Vaccination of Health-Care Workers--California and Minnesota.  MMWR Morb Mortal Wkly Rep; 54 (8): 196-199; March 4, 2005.

  10. Ada, G.  Overview of Vaccines and Vaccination.  Mol Biotechnol; 29 (3): 255-272; March, 2005.

  11. Baggs, J.; Chen, R. T.; Damon, I. K.; Rotz, L.; Allen, C.; Fullerton, K. E.; Casey, C.; Nordenberg, D.; Mootrey, G.  Safety Profile of Smallpox Vaccine: Insights From the Laboratory Worker Smallpox Vaccination Program.  Clin Infect Dis; 40 (8): 1133-1140; April 15, 2005.

  12. Bechir, M.; Schelling, E.; Wyss, K.; Daugla, D. M.; Daoud, S.; Tanner, M.; Zinsstag, J.  [An Innovative Approach Combining Human and Animal Vaccination Campaigns in Nomadic Settings of Chad: Experiences and Costs].   Med Trop (Mars); 64 (5): 497-502; 2004.

  13. Bogaert, D.; Veenhoven, R. H.; Ramdin, R.; Luijendijk, I. H.; Rijkers, G. T.; Sanders, E. A.; de, Groot R.; Hermans, P. W.   Pneumococcal Conjugate Vaccination Does Not Induce a Persisting Mucosal IgA Response in Children With Recurrent Acute Otitis Media.   Vaccine; 23 (20): 2607-2613; April 8, 2005.

  14. Bompart, F.  Vaccination Strategies for the Last Stages of Global Polio Eradication.   Indian Pediatr; 42 (2): 163-169; February, 2005.

  15. Bronstein, D. E.; Cotliar, J.; Votava-Smith, J. K.; Powell, M. Z.; Miller, M. J.; Cherry, J. D.  Recurrent Papular Urticaria After Varicella Immunization in a Fifteen-Month-Old Girl.   Pediatr Infect Dis J; 24 (3): 269-270; March, 2005.

  16. Brotherton, J.; McIntyre, P.; Puech, M.; Wang, H.; Gidding, H.; Hull, B.; Lawrence, G.; MacIntyre, R.; Wood, N.; Armstrong, D.  Vaccine Preventable Diseases and Vaccination Coverage in Australia 2001 to 2002.   Commun Dis Intell; 28 (Suppl 2): vii-S116; December, 2004.

  17. Bursztyn, M.  Vascular Events After Acute Infection or Vaccination.   N Engl J Med; 352 (11): 1151-1153; March 17, 2005.

  18. Castillo-Febres, O.; Lopez, G.; Ortegal, F.; Estopinan, M.; Casanova-Escalona, L.; Sanchez-Naveda, M.; Decker, M.; Edwards, K. M.  [Oropharyngeal Carriers in Venezuelan Children in Two Child Care Settings, Vaccinated or Not With Haemophilus Influenzae Type b Tetanus Toxoid Conjugate Vaccine (PRP-T)]. Invest Clin; 46 (1): 15-24; March, 2005.

  19. Czaja, C.; Crossette, L.; Metlay, J. P.  Accuracy of Adult Reported Pneumococcal Vaccination Status of Children.    Ann Epidemiol; 15 (4): 253-256; April, 2005.

  20. De, Serres G.; Duval, B.  Pertussis Vaccination Beyond Childhood.   Lancet; 365 (9464): 1015-1016; March 16, 2005.

  21. Ehreth, J.  The Economics of Vaccination From a Global Perspective: Present and Future.   Expert Rev Vaccines; 4 (1): 19-21; February, 2005.

  22. Erickson, L. J.; De, Wals P.; Farand, L.  An Analytical Framework for Immunization Programs in Canada.   Vaccine; 23 (19): 2470-2476; March 31, 2005.

  23. Fatovic-Ferencic, S.; Buklijas, T.  Vaccination: Fascination and Poetry.    Croat Med J; 46 (1): 148-149; February, 2005.

  24. Fiscella, K.  Commentary-Anatomy of Racial Disparity in Influenza Vaccination.   Health Serv Res; 40 (2): 539-550; April, 2005.

  25. Gabutti, G.; Guido, M.; Quattrocchi, M.; Zizza, A.; De, Donno A.; Gasparini, R.; Donatelli, I.; Prato, R.; Germinario, C.; Crovari, P.  Surveillance of Influenza in Apulia, Italy, 1999-2000, 2000-2001, 2001-2002, and 2002-2003 Seasons.   Med Mal Infect; 34 (10): 469-476; October, 2004.

  26. Geier, D.; Geier, M. R.  Neurodevelopmental Disorders Following Thimerosal-Containing Childhood Immunizations: a Follow-Up Analysis.   Int J Toxicol; 23 (6): 369-376; November, 2004.

  27. Gill, T.; Taylor, A. W.; Kempe, A.; Pickering, S.; Watson, M.  Prevalence of Influenza Vaccination in South Australian Aged Care Homes.   Aust N Z J Public Health; 29 (1): 38-43; February, 2005.

  28. Gindi, M.; Oravitz, P.; Sexton, R.; Shpak, M.; Eisenhart, A.  Unreliability of Reported Tetanus Vaccination Histories.   Am J Emerg Med; 23 (2): 120-122; March, 2005.

  29. Grabowsky, M.; Nobiya, T.; Ahun, M.; Donna, R.; Lengor, M.; Zimmerman, D.; Ladd, H.; Hoekstra, E.; Bello, A.; Baffoe-Wilmot, A.; Amofah, G.  Distributing Insecticide-Treated Bednets During Measles Vaccination: a Low-Cost Means of Achieving High and Equitable Coverage.   Bull World Health Organ; 83 (3): 195-201; March, 2005.

  30. Greig, J. E.; Patel, M. S.; Clements, M. S.; Taylor, N. K.  Control Strategies for Q Fever Based on Results of Pre-Vaccination Screening in Victoria, 1988 to 2001.   Aust N Z J Public Health; 29 (1): 53-57; February, 2005.

  31. Gutierrez, Hernando R.; Alvarez, Pasquin M.; Sesmero, Lillo M.; Martin, Martin S.  [Vaccination of Immigrant Children: How Do They Reach Our Clinics?].   Aten Primaria; 35 (3): 164; February 28, 2005.

  32. Hallauer, J. F.; Neuschaefer-Rube, N.  Influenza Vaccination of Hospital Staff in Germany: a Five-Year Survey on Vaccination Coverage and Policies: Identified Deficits in Influenza Immunisation Campaigns for Hospital Employees.   Soz Praventivmed; 50 (1): 38-44; 2005.

  33. Hanna, J. N.; Bullen, R. C.; Andrews, D. E.  The Acceptance of Three Simultaneous Vaccine Injections Recommended at 12 Months of Age.   Commun Dis Intell; 28 (4): 493-496; 2004.

  34. Hebert, P. L.; Frick, K. D.; Kane, R. L.; McBean, A. M.  The Causes of Racial and Ethnic Differences in Influenza Vaccination Rates Among Elderly Medicare Beneficiaries.   Health Serv Res; 40 (2): 517-538; April, 2005.

  35. Hewlett, E. L.; Edwards, K. M.  Clinical Practice. Pertussis--Not Just for Kids.   N Engl J Med; 352 (12): 1215-1222; March 24, 2005.

  36. Horby, P. W.; Williams, A.; Burgess, M. A.; Wang, H.  Prevalence and Determinants of Influenza Vaccination in Australians Aged 40 Years and Over--a National Survey.   Aust N Z J Public Health; 29 (1): 35-37; February, 2005.

  37. Hoyle, T.  What Information Should Be Integrated With the Childhood Immunization Registry?   Mich Med; 104 (1): 18-19; January, 2005.

  38. Kaiser, J.  Biodefense. Report Faults Smallpox Vaccination.   Science; 307 (5715): 1540; March 11, 2005.

  39. Keane, M. T.; Walter, M. V.; Patel, B. I.; Moorthy, S.; Stevens, R. B.; Bradley, K. M.; Buford, J. F.; Anderson, E. L.; Anderson, L. P.; Tibbals, K.; Vernon, T. M.  Confidence in Vaccination: a Parent Model.   Vaccine; 23 (19): 2486-2493; March 31, 2005.

  40. Kilbourne, E. D.  Intradermal Vaccination Against Influenza.   N Engl J Med; 352 (10): 1044-1046; March 10, 2005.

  41. Koch, D.; Thompson, L.; Swart, B.  Looking Ahead to Successful Immunization Programs.   Can Nurse; 101 (2): 14-15; February, 2005.

  42. Kumar, A.; Murray, D. L.; Havlichek, D. H.   Immunizations for the College Student: a Campus Perspective of an Outbreak and National and International Considerations.   Pediatr Clin North Am; 52 (1): 229-41, xi; February, 2005.

  43. Lambert, S.; O'Grady, K. A.; Gabriel, S.; Carter, R.; Nolan, T.  The Cost of Seasonal Respiratory Illnesses in Australian Children: the Dominance of Patient and Family Costs and Implications for Vaccine Use.   Commun Dis Intell; 28 (4): 510-516; 2004.

  44. Lawrence, G.; Boyd, I.  Surveillance of Adverse Events Following Immunisation for Children Aged Less Than 7 Years, 1 January to 30 June 2004.   Commun Dis Intell; 28 (4): 490-492; 2004.

  45. Levi, B. H.; Brown, G.  Description of the Immunization Information Database: a Tool for Investigating Allegations Made Against Childhood Immunizations. Vaccine; 23 (16): 2009-2015; March 14, 2005.

  46. Machado, C. M.; de, Souza, V; Sumita, L. M.; da, Rocha, I; Dulley, F. L.; Pannuti, C. S.  Early Measles Vaccination in Bone Marrow Transplant Recipients.   Bone Marrow Transplant; 35 (8): 787-791; March 7, 2005.

  47. Manian, F. A.  Intradermal Vaccination Against Influenza.   N Engl J Med; 352 (10): 1044-1046; March 10, 2005.

  48. Maubec, E.; Pinquier, L.; Viguier, M.; Caux, F.; Amsler, E.; Aractingi, S.; Chafi, H.; Janin, A.; Cayuela, J. M.; Dubertret, L.; Authier, F. J.; Bachelez, H.  Vaccination-Induced Cutaneous Pseudolymphoma.   J Am Acad Dermatol; 52 (4): 623-629; April, 2005.

  49. Miron, D.; Lavi, I.; Kitov, R.; Hendler, A.  Vaccine Effectiveness and Severity of Varicella Among Previously Vaccinated Children During Outbreaks in Day-Care Centers With Low Vaccination Coverage. Pediatr Infect Dis J; 24 (3): 233-236; March, 2005.

  50. Mitchell, V.; Walker, D.; Zuber, P.; Lydon, P.; Ahun, M.  Evidenced-Based Decision Making About Hib Vaccination.    Lancet; 365 (9463): 936-937; March 9, 2005.

  51. Munoz-Lope, F.  Vaccination. Yes or No?   Allergol Immunopathol (Madr); 33 (1): 1-6; January, 2005.

  52. Navas, E.; Salleras, L.; Gisbert, R.; Dominguez, A.; Timoner, E.; Ibanez, D.; Prat, A.  Cost-Benefit and Cost-Effectiveness of the Incorporation of the Pneumococcal 7-Valent Conjugated Vaccine in the Routine Vaccination Schedule of Catalonia (Spain).   Vaccine; 23 (17-18): 2342-2348; March 18, 2005.

  53. Nicholls, S.; Carroll, K.; Crofts, J.; Ben-Eliezer, E.; Paul, J.; Zambon, M.; Joseph, C. A.; Verlander, N. Q.; Goddard, N. L.; Watson, J. M.  Outbreak of Influenza A (H3N2) in a Highly-Vaccinated Religious Community: a Retrospective Cohort Study.   Commun Dis Public Health; 7 (4): 272-277; December, 2004.

  54. Oh, R. C.  Folliculitis After Smallpox Vaccination: a Report of Two Cases.   Mil Med; 170 (2): 133-136; February, 2005.

  55. Ohkusa, Y.  Policy Evaluation for the Subsidy for Influenza Vaccination in Elderly.   Vaccine; 23 (17-18): 2256-2260; March 18, 2005.

  56. Ohrui, T.; Nakayama, K.; Fukushima, T.; Chiba, H.; Sasaki, H.  [Prevention of Elderly Pneumonia by Pneumococcal, Influenza and BCG Vaccinations].   Nippon Ronen Igakkai Zasshi; 42 (1): 34-36; January, 2005.

  57. Olsen, G. W.; Steinberg, M. E.; Ley, C. A.   Worksite Influenza Immunization Programs. Insight into the Implementation and Cost-Benefit.   AAOHN J; 53 (3): 105-110; March, 2005.

  58. Patel, R.; Longini, I. M., Jr.; Halloran, M. E.  Finding Optimal Vaccination Strategies for Pandemic Influenza Using Genetic Algorithms.   J Theor Biol; 234 (2): 201-212; May 21, 2005.

  59. Phillips, A. C.; Carroll, D.; Burns, V. E.; Drayson, M.  Neuroticism, Cortisol Reactivity, and Antibody Response to Vaccination.  Psychophysiology; 42 (2): 232-238; March, 2005.

  60. Poland, G. A.; Tosh, P.; Jacobson, R. M.  Requiring Influenza Vaccination for Health Care Workers: Seven Truths We Must Accept.   Vaccine; 23 (17-18): 2251-2255; March 18, 2005.

  61. Poland, G. A.; Grabenstein, J. D.; Neff, J. M.  The US Smallpox Vaccination Program: a Review of a Large Modern Era Smallpox Vaccination Implementation Program.   Vaccine; 23 (17-18): 2078-2081; March 18, 2005.

  62. Rock, M. T.; Yoder, S. M.; Wright, P. F.; Talbot, T. R.; Edwards, K. M.; Crowe, J. E., Jr.  Differential Regulation of Granzyme and Perforin in Effector and Memory T Cells Following Smallpox Immunization.   J Immunol; 174 (6): 3757-3764; March 15, 2005.

  63. Root-Bernstein, R. S.  Vaccination Markers: Designing Unique Antigens to Be Added to Vaccines to Differentiate Between Natural Infection and Vaccination.   Vaccine; 23 (17-18): 2057-2059; March 18, 2005.

  64. Schwartz, B.; Gellin, B.  Vaccination Strategies for an Influenza Pandemic.   J Infect Dis; 191 (8): 1207-1209; April 15, 2005.

  65. Schwarz, Chavarri H.; Ortuno Lopez, J. L.; Lattur, Vilchez A.; Pedrera, Carbonell, V; Orozco, Beltran D.; Gil, Guillen, V  [Can We Improve Influenza Vaccination Rates in Older People With Chronic Diseases?].   Aten Primaria; 35 (4): 178-182; March 15, 2005.

  66. Sharifi, N.; Mofrad, P. S.  Vascular Events After Acute Infection or Vaccination.   N Engl J Med; 352 (11): 1151-1153; March 17, 2005.

  67. Shatz, D. V.  Vaccination Considerations in the Asplenic Patient. Expert Rev Vaccines; 4 (1): 27-34; February, 2005.

  68. Slifka, M. K.  The Future of Smallpox Vaccination: Is MVA the Key?  Med Immunol; 4 (1): 2; March 1, 2005.

  69. Smith, P. J.; Hoaglin, D. C.; Battaglia, M. P.; Khare, M.; Barker, L. E.  Statistical Methodology of the National Immunization Survey, 1994-2002.   Vital Health Stat 2;(138): 1-55; March, 2005.

  70. Sokos, D. R.  Pharmacists' Role in Increasing Pneumococcal and Influenza Vaccination.   Am J Health Syst Pharm; 62 (4): 367-377; February 15, 2005.

  71. Stephenson, I.; Bugarini, R.; Nicholson, K. G.; Podda, A.; Wood, J. M.; Zambon, M. C.; Katz, J. M.  Cross-Reactivity to Highly Pathogenic Avian Influenza H5N1 Viruses After Vaccination With Nonadjuvanted and MF59-Adjuvanted Influenza A/Duck/Singapore/97 (H5N3) Vaccine: A Potential Priming Strategy.   J Infect Dis; 191 (8): 1210-1215; April 15, 2005.

  72. Szucs, T. D.  Health Economic Research on Vaccinations and Immunisation Practices--an Introductory Primer.   Vaccine; 23 (17-18): 2095-2103; March 18, 2005.

  73. Victora, C. G.  Reaching the Underserved.   Am J Public Health; 95 (2): 195; February, 2005.

  74. Wang, S. T.; Lee, L. T.; Chen, L. S.; Chen, T. H.  Economic Evaluation of Vaccination Against Influenza in the Elderly: an Experience From a Population-Based Influenza Vaccination Program in Taiwan. Vaccine; 23 (16): 1973-1980; March 14, 2005.

  75. Watson, M.; Roche, P.; Bayley, K.; Bell, J. M.; Collignon, P.; Gilbert, G. L.; Hogg, G.; Keil, A. D.; Krause, V.; Murphy, D.; Smith, H. V.; Brown, M.; Stylianopoulos, J.; Turnidge, J.  Laboratory Surveillance of Invasive Pneumococcal Disease in Australia, 2003 Predicting the Future Impact of the Universal Childhood Conjugate Vaccine Program. Commun Dis Intell; 28 (4): 455-464; 2004.

  76. Waugh, N.  Commentary: Pneumococcal Immunization May Not Be Cost-Effective in the Elderly in Developed Countries.   Int J Epidemiol; March 11, 2005. [Epub ahead of print]

  77. Weller, T. H.  Intradermal Vaccination Against Influenza.   N Engl J Med; 352 (10): 1044-1046; March 10, 2005.

  78. Wilson, S. J.  Factors Affecting Implementation of the U.S. Smallpox Vaccination Program, 2003.   Public Health Rep; 120 (1): 3-5; January, 2005.

[Top]